Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

1,393

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2014

Conditions
Pandemic H5N1 Influenza
Interventions
BIOLOGICAL

Adjuvanted H5N1 pandemic influenza vaccine

Comparison of two doses of aH5N1c vaccine

Trial Locations (23)

2292

42 Hunter Clinical Research, Newcastle

4066

44 Wesley Research Institute Clinical Trials Center, Auchenflower

5000

40 CMAX, Adelaide

6009

41 Linear Clinical Research, Nedlands

6872

45 Childrens Clin Rsrch Facility, Perth

8041

51 Riccarton Clinic, Riccarton

8244

50 Southern Clinical Trials, Beckenham

10330

72 Faculty of Medicine, Chulalongkorn University - Queen Saovabha Memorial Institute, Bangkok

10400

71 Phramongkutklao Hospital, Bangkok

10700

73 Siriraj Clinical Research Ctr, Bangkok

13760

6 Regional Clinical Research Endwell,, Endwell

33024

5 Broward Research Group Pembroke Pines, Hollywood

50200

74 Chiang Mai Uni Hospital Clinical Trial Center, Bangkok

63141

2 Mercy Health Research, St Louis

3 Saint Louis University, St Louis

67207

7 Heartland Rsrch Ass LLC, Wichita

9 Heartland Research Associates, Wichita

78705

4 Benchmark Medical Research, Austin

78745

12 Tekton Research, Georgetown

84095

11 Jordan River Family Medicine, South Jordan

84109

8 J. Lewis Research Inc., Salt Lake City

84121

10 Foothill Family Clinic, South Cottonwood Heights

85253

1 Tatum Highlands Med Ass PLLC, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Novartis Vaccines

INDUSTRY